Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

9/6/22 md High Risk - High Alert Drugs
September 27, 2022

From: "Michele Durda" <michele.durda@hhsys.org>
To: "Pharmacy Department" <grp_pharmacy@hhsys.org>
Sent: Tuesday, September 6, 2022 4:44:12 PM
Subject: High Risk - High Alert Drugs

 

Good afternoon,

Jill and I have recently updated the High Risk - High Alert (HR/HA) Action Grid for 2022. This document lists many of the interventions that we have implemented to prevent errors with HR/HA Drugs. Please take a minute to review all of the important activities that pharmacy performs to protect our patients from harm.

Don't forget, that Joint Commission may ask about what we do to safeguard HR/HA drugs. This could be a good resource for the TJC Survey.

You may access it through FormWEB on the Joint Commission/Regulatory/Safety page:






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved